Integrated m6A RNA Methylation Analysis by LC-MS/MS and MeRIP-Seq
Has your experimental condition changed the total m6A burden, redistributed m6A enrichment across specific transcripts, or both? A single assay cannot distinguish these possibilities. This coordinated service measures global m6A abundance by LC-MS/MS and maps transcriptome-wide m6A-enriched regions by MeRIP-seq using a matched study design.
The two evidence layers are analyzed separately and then interpreted together. You receive a quantitative global readout, a transcript-level enrichment landscape, differential m6A results, and a prioritized set of genes and pathways for follow-up.
Key Highlights:
- Global m6A Quantification: LC-MS/MS measures m6A relative to adenosine in the selected RNA fraction, supporting direct between-group comparison at the global level.
- Transcriptome-Wide Profiling: MeRIP-seq identifies m6A-enriched RNA regions and shows how enrichment is distributed across transcripts and transcript features.
- Matched Evidence Layers: Coordinated RNA fraction selection and sample splitting keep both assays aligned to the same biological question.
- Integrated Interpretation: Global abundance, differential enrichment, transcript annotation, pathway results, and optional expression data are reviewed together to prioritize candidates.
What This Integrated m6A Analysis Can Tell You
The combined study answers two different scales of the same RNA methylation question: whether total m6A abundance changes and where enrichment shifts across the transcriptome. Keeping these scales separate before integration prevents a global average from being mistaken for uniform transcript-level change.
- Has global m6A abundance changed? LC-MS/MS provides a quantitative m6A readout, commonly expressed as an m6A/A ratio when appropriate to the assay design. This gives you an orthogonal measure for comparing the selected RNA fraction across conditions.
- Where are m6A-enriched regions located? MeRIP-seq maps enrichment peaks to transcripts and features such as 5' UTRs, coding regions, stop-codon-proximal regions, and 3' UTRs. This reveals redistribution even when the global level changes little.
- Which transcripts differ between groups? Differential enrichment analysis identifies reproducible regions that gain or lose MeRIP-seq signal after normalization to matched input RNA.
- Which findings merit validation? Integrated ranking considers LC-MS/MS direction, peak reproducibility, enrichment magnitude, transcript location, pathway relevance, and optional expression evidence. This reduces a long peak list to a tractable set of follow-up candidates.
For a broader overview of available technologies, explore our RNA Modification Service.
Research Applications
Integrated m6A analysis is most useful when a study needs to connect a global modification trend with specific transcripts, regions, or pathways. Each application below starts with a concrete research decision rather than a broad field label.
When METTL3, METTL14, FTO, ALKBH5, or another regulator is perturbed, LC-MS/MS shows whether the selected RNA fraction undergoes a global m6A shift. MeRIP-seq then identifies which transcripts and regions gain or lose enrichment, helping separate broad enzymatic effects from selective targets for downstream functional assays.
When a treatment changes RNA metabolism, global quantification establishes whether m6A abundance moves at the whole-fraction level, while differential MeRIP-seq identifies treatment-responsive transcripts and pathways. Candidate ranking helps researchers select focused targets instead of following every differential region.
During differentiation, reprogramming, or developmental time courses, an unchanged global average can coexist with extensive redistribution among transcripts. Combining both assays reveals this distinction and helps identify stage-specific m6A programs linked to RNA processing or expression.
Heat, hypoxia, nutrient change, oxidative stress, or environmental exposure can affect RNA modification and expression together. Global and transcript-level evidence helps determine whether m6A remodeling is broad, pathway-focused, or restricted to selected response genes.
In infection or immune-stimulation studies, LC-MS/MS compares total m6A abundance and MeRIP-seq locates differential enrichment on host or pathogen-associated transcripts, subject to reference quality. Functional analysis connects those signals with immune pathways and prioritizes targets for mechanistic validation.
With matched RNA-seq, transcripts can be classified by methylation and expression direction. This distinguishes candidates whose m6A enrichment is associated with increased expression from those showing the opposite pattern, creating a focused basis for stability, translation, or reader-protein studies.
How LC-MS/MS and MeRIP-Seq Work Together
LC-MS/MS and MeRIP-seq measure different properties. LC-MS/MS quantifies modified nucleosides after RNA digestion, while MeRIP-seq enriches and sequences RNA fragments containing m6A. Their results should therefore be treated as complementary evidence, not interchangeable validation.
- Define the RNA Fraction: Select the biologically relevant fraction, such as poly(A)-enriched RNA or another suitable preparation. Using the same fraction across groups and assay branches makes the global and transcriptome-wide results comparable.
- Quantify Global m6A by LC-MS/MS: RNA is digested to nucleosides, separated chromatographically, and detected by characteristic mass transitions. Calibration-based measurement supports a quantitative m6A/A readout. This means you can compare overall abundance without incorrectly assigning the signal to a specific transcript.
- Map Enriched Regions by MeRIP-Seq: RNA is fragmented, an aliquot is retained as input, and m6A-containing fragments are enriched with an anti-m6A antibody. IP and input libraries are sequenced in parallel. Input normalization helps distinguish enrichment from underlying transcript abundance, so differential candidates are less likely to reflect expression alone.
- Evaluate Branch-Specific Quality: LC-MS/MS review includes calibration behavior, retention-time consistency, and replicate performance. MeRIP-seq review includes RNA and library quality, alignment, IP-versus-input enrichment, replicate concordance, and peak-level diagnostics.
- Integrate Without Collapsing the Scales: Global m6A change is compared with the number, direction, location, and functional context of differential regions. This shows whether a phenotype is associated mainly with an overall abundance shift, redistribution across transcripts, or both.
LC-MS/MS measures global m6A abundance, while MeRIP-seq maps m6A-enriched RNA regions; matched design allows the two scales to be interpreted together.
This paired design creates three decision-relevant advantages. Quantitative LC-MS/MS prevents peak counts from being used as a proxy for total m6A abundance. Input-normalized MeRIP-seq places the global signal into transcript and region context. Matched biological material makes agreement or disagreement between the two scales interpretable rather than a batch-driven artifact.
Discuss Your StudyIntegrated Service Workflow
The service workflow keeps project execution concise while preserving the controls needed for two coordinated assays. Assay-specific quality checks are completed before the global and regional evidence is combined.
A coordinated workflow keeps sample handling, assay execution, and integrated interpretation aligned across both evidence layers.
- Study Design: Confirm comparison groups, biological replication, RNA fraction, optional expression data, and validation priorities.
- RNA Preparation and QC: Extract or receive RNA and assess concentration, purity, integrity, and suitability for the selected workflow.
- Matched Sample Split: Allocate comparable aliquots to the LC-MS/MS and MeRIP-seq branches while retaining the planned input control.
- Parallel Assays: Perform quantitative nucleoside analysis by LC-MS/MS and m6A enrichment, library preparation, and sequencing for MeRIP-seq.
- Branch Analysis and Integration: Complete assay-specific QC and statistics before comparing global and transcriptome-wide patterns.
- Report and Follow-Up: Deliver scientific results, data files, interpretation notes, and a prioritized list for optional targeted validation.
Bioinformatics and Integrated Interpretation
The analysis preserves the distinct logic of each assay and then builds a transparent evidence bridge between them. Customers can see which conclusion comes from quantitative mass spectrometry, which comes from enrichment sequencing, and which depends on integration.
Assay-specific quality control and analysis remain separate until the global and regional evidence is ready for integrated interpretation.
LC-MS/MS Analysis:
- Calibration and assay-quality review
- Peak integration and m6A and adenosine signal assessment
- Quantitative m6A/A calculation where applicable
- Replicate summary and between-group comparison
- Review of outliers and project-specific normalization
MeRIP-Seq Analysis:
- Raw read quality control, adapter trimming, and alignment
- Separate processing of IP and matched input libraries
- Enrichment-region calling and transcript-feature annotation
- Replicate concordance and consensus peak construction
- Metagene distribution and motif enrichment
- Differential m6A enrichment analysis between conditions
- Functional enrichment of genes associated with differential regions
Integrated Interpretation:
- Compare global m6A direction with increased and decreased enrichment regions
- Distinguish an abundance shift from transcriptome-level redistribution
- Rank candidates by reproducibility, enrichment magnitude, transcript location, and functional relevance
- Optionally classify candidates by joint methylation and expression patterns when matched RNA-seq data are available
- Generate a project summary connecting assay results to the original research question
Optional expression integration can be extended through RNA-seq and epigenomic data analysis when the project needs additional regulatory context.
Deliverables and Representative Results
Deliverables are organized around the questions the study can answer. Raw and processed files remain available for reanalysis, while the report emphasizes interpretable results and candidate selection.
Illustrative outputs connect quantitative global m6A change with regional enrichment, transcript context, and candidate prioritization.
Global m6A Quantification:
- Quantitative m6A readout and m6A/A ratio where applicable
- Calibration and assay-quality summary
- Replicate-level and group-level comparison tables
- Clear notes on the RNA fraction used for measurement
Transcriptome-Wide Profiling:
- Raw sequencing data and quality-control summaries
- Alignment files and IP/input coverage tracks
- Consensus and sample-level enrichment-region files
- Peak-to-transcript and transcript-feature annotations
- Metagene profiles, motif results, and representative browser tracks
- Differential enrichment tables and functional summaries
Integrated Project Results:
- Global-versus-regional interpretation summary
- Candidate-prioritization matrix with supporting evidence
- Optional methylation-expression quadrant analysis
- Final report with methods, QC, analysis parameters, figures, and interpretation notes
The results figure is illustrative and does not represent a fixed performance claim or a customer dataset. Exact outputs depend on the comparison design and selected analysis modules.
Sample Requirements and Key Considerations
Published service specifications provide useful planning values for each assay branch, but an integrated project must also reserve material for QC, RNA fractionation, and matched sample splitting. The figures below are branch-specific references rather than a single combined minimum.
| Sample Type | MeRIP-Seq Branch Reference | LC-MS/MS Branch Reference | QC Requirements | Integrated Project Notes |
|---|---|---|---|---|
| Extracted Total RNA | ≥5 µg for a standard workflow; ≥1 µg for a low-input workflow | 0.5–1 µg RNA | RIN ≥7.0; OD260/280 = 1.8–2.1 | Additional material is required for QC, RNA fractionation, and matched sample splitting. Final combined input is confirmed during project assessment. |
| Poly(A)-Enriched mRNA | ≥500 ng | 0.5–1 µg RNA | Clear size distribution with minimal rRNA contamination | Both assay branches should use equivalent RNA fractions. Final combined input depends on the planned assay allocation. |
| Cell Pellets | ≥2 × 10^6 cells | RNA is extracted before assay allocation | Viability ≥85%; PBS-washed; freeze promptly | Higher input may be requested when RNA yield is low or two assay branches must be supported. |
| Fresh-Frozen Tissue | ≥50 mg | RNA is extracted before assay allocation | Flash-frozen; avoid repeated freeze-thaw cycles | Tissue type, expected RNA yield, inhibitors, and reference annotation quality determine the final amount. |
Key Considerations:
- Biological Replication: Replicates allow differential enrichment models to estimate biological variability, so candidate peaks are less likely to reflect one atypical sample.
- RNA Fraction Selection: Total RNA, rRNA-depleted RNA, and poly(A)-enriched RNA contain different modification backgrounds. Matching the fraction across samples and assay branches is essential for meaningful integration.
- Limited Material: If input is insufficient for a coordinated split, a low-input m6A profiling workflow or targeted assay may be more informative than forcing both branches from compromised material.
- Matched Expression Data: RNA-seq is not required for the core service, but matched expression data help distinguish modification-associated changes from shifts driven mainly by transcript abundance.
These values are planning references for the individual assay branches, not guaranteed combined minima. Final requirements are confirmed according to sample condition, RNA fraction, organism, assay allocation, and study design.
Case Study: Host m6A Remodeling During Malaria Parasite Infection
Method Selection Guide
The right design depends on whether the project needs global abundance, transcriptome-wide localization, single-nucleotide assignment, or targeted validation. The comparison below helps match the evidence type to the research decision.
| Approach | Primary Answer | Resolution and Scale | Main Limitation | Best Fit |
|---|---|---|---|---|
| LC-MS/MS Alone | How much m6A is present in the selected RNA fraction? | Quantitative nucleoside-level global readout | Does not identify the modified transcript or region | Global m6A comparison across conditions |
| MeRIP-Seq Alone | Where are m6A-enriched RNA regions located? | Transcriptome-wide enrichment regions, generally fragment-level | Not a direct global stoichiometric measurement | Discovery of differential regions and associated transcripts |
| Integrated LC-MS/MS and MeRIP-Seq | Has global abundance changed, where is enrichment redistributed, and how do the scales relate? | Global quantitative evidence plus transcriptome-wide regional mapping | Requires sufficient matched material and coordinated design | Comparative studies needing quantification and localization |
| Single-Nucleotide m6A Method | Which adenosine is modified and, for some methods, at what fraction? | Site-level mapping; method-dependent quantification | May have sequence, chemistry, input, or analysis constraints | Projects where nucleotide-level assignment is the primary endpoint |
Best for: Use the integrated service when the central question requires both a global m6A comparison and transcript-level localization across the same biological conditions.
Not the best fit: If the study only needs to test one known transcript or a small candidate panel, MeRIP-qPCR may be more efficient. If single-nucleotide assignment is essential, consider a site-resolved method such as GLORI-seq. If only total modification abundance matters, the broader RNA modification LC-MS/MS service may be sufficient.
Request a Project AssessmentFrequently Asked Questions
References
- Wang, L., Wu, J., Liu, R., et al. "Epitranscriptome profiling of spleen mRNA m6A methylation reveals pathways of host responses to malaria parasite infection." Frontiers in Immunology, vol. 13, 2022, article 998756.
- Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., et al. "Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq." Nature, vol. 485, 2012, pp. 201-206.
- Meyer, K. D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C. E., and Jaffrey, S. R. "Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons." Cell, vol. 149, no. 7, 2012, pp. 1635-1646.
- McIntyre, A. B. R., Gokhale, N. S., Cerchietti, L., Jaffrey, S. R., Horner, S. M., and Mason, C. E. "Limits in the detection of m6A changes using MeRIP/m6A-seq." Scientific Reports, vol. 10, 2020, article 6590.
- Yang, X., Triboulet, R., Liu, Q., Sendinc, E., and Gregory, R. I. "Exon junction complex shapes the m6A epitranscriptome." Nature Communications, vol. 13, 2022, article 7904.
For research purposes only. Not intended for clinical diagnosis, treatment, or individual health assessments.